2010 - Review: Probiotics improve symptoms in adults with the irritable bowel syndrome

van Zanten, Sander Veldhuyzen
September 2010
ACP Journal Club;9/21/2010, Vol. 153 Issue 3, p6
Academic Journal
The article presents a study tracing the effectiveness of probiotics in the treatment of irritable bowel syndrome (IBS). According to meta-analysis by P. Moayyedi and colleagues use of probiotics including Lactobacillus, Bifidobacterium and Streptococcus reduce symptoms of IBS in adults. A comparison chart depicting outcomes for probiotics and placebo in the treatment of IBS, is also presented.


Related Articles

  • Meta-analysis of probiotics for the treatment of irritable bowel syndrome. McFarland, Lynne V.; Dublin, Sascha; Costa, Francesco; Vandenplas, Yvan // World Journal of Gastroenterology;5/7/2008, Vol. 14 Issue 17, p2650 

    Irritable bowel syndrome (IBS) is a chronic condition affecting 3%-25% of the general population. As no curative treatment is available, therapy is aimed at reducing symptoms, often with little success. Because alteration of the normal intestinal microflora has been observed in IBS, probiotics...

  • Continuing Medical Education Questions: April 2009. Scolapio, James S.; Buchner, Anna M.; Gill, Kanwar R. S.; Hassan, Muhammad // American Journal of Gastroenterology (Springer Nature);Apr2009, Vol. 104 Issue 4, p1050 

    A quiz concerning the use of probiotics in the treatment of irritable bowel syndrome is presented.

  • The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. Han Hee Lee; Yoon Young Choi; Myung-Gyu Choi // Journal of Neurogastroenterology & Motility;Apr2014, Vol. 20 Issue 2, p152 

    Background/Aims: Hypnotherapy is considered as a promising intervention for irritable bowel syndrome (IBS), but the evidence is still limited. The aims of this study were to conduct a systematic review and meta-analysis to estimate the efficacy of hypnotherapy for the treatment of IBS. Methods:...

  • Diet Therapy in Irritable Bowel Syndrome; A review. Hashemian, Maryam; Nasrabadi, Fatemeh Mohammadi; Hekmatdoost, Azita; Poustchi, Hossein; Malekzadeh, Reza // Iranian Journal of Gastroenterology & Hepatology (GOVARESH);Autumn2014, Vol. 19 Issue 3, p155 

    Background: Irritable Bowel Syndrome (IBS) has the most common functional gastrointestinal disease and has among the most common reasons for outpatients doctor visit both in primary and specialty clinics. Patients suffer from lifelong chronic abdominal pain, diarrhea, constipation, bloating and...

  • Gut microbiome, surgical complications and probiotics. Stavrou, George; Kotzampassi, Katerina // Annals of Gastroenterology;2017, Vol. 30 Issue 1, p45 

    The trigger for infectious complications in patients following major abdominal operations is classically attributed to endogenous enteral bacterial translocation, due to the critical condition of the gut. Today, extensive gut microbiome analysis has enabled us to understand that almost all...

  • Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach. Soldi, Sara; Vasileiadis, Sotirios; Uggeri, Francesca; Campanale, Mariachiara; Morelli, Lorenzo; Fogli, Maria Vittoria; Calanni, Fiorella; Grimaldi, Maria; Gasbarrini, Antonio // Clinical & Experimental Gastroenterology;Dec2015, Vol. 8, p309 

    Rifaximin, with its low systemic absorption, may represent a treatment of choice for irritable bowel syndrome (IBS), mainly due to its ability to act on IBS pathogenesis, through the influence on gut microbiota. The aim of the present study was to assess, by biomolecular tools, the rifaximin...

  • The Role of Hypnotherapy in Irritable Bowel Syndrome: Systematic Evaluation of 1344 Cases with Meta-Analysis. Mann, Nirmal S. // International Medical Journal;Oct2014, Vol. 21 Issue 5, p447 

    Purpose: Irritable bowel syndrome (IBS) is a very common GI problem; it may account for 55% of the gastroenterologists' work load. It is characterized by abdominal pain, abdominal distention, constipation and/or diarrhea in the absence of organic disease. Symptomatic Rx of IBS sometimes is...

  • Acupuncture for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Manheimer, Eric; Wieland, L Susan; Cheng, Ke; Li, Shih Min; Shen, Xueyong; Berman, Brian M; Lao, Lixing // American Journal of Gastroenterology;Jun2012, Vol. 107 Issue 6, p835 

    OBJECTIVES:Evidence-based treatment guidelines have been unable to provide evidence-based guidance on the effects of acupuncture for irritable bowel syndrome (IBS) because the only previous systematic review included only small, heterogeneous, and methodologically unsound trials. We conducted a...

  • Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. Wilson, Bridgette; Rossi, Megan; Dimidi, Eirini; Whelan, Kevin // American Journal of Clinical Nutrition;Apr2019, Vol. 109 Issue 4, p1098 

    Background Irritable bowel syndrome (IBS) and other functional bowel disorders (FBDs) are prevalent disorders with altered microbiota. Prebiotics positively augment gut microbiota and may offer therapeutic potential. Objectives The aim of this study was to investigate the effect of prebiotics...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics